Investigación - Nuestro equipo

Pía Alberione holds a bachelor's degree in Biochemistry from the University of Córdoba in Argentina and a Master’s degree in Infection Biology from the Hannover Medical School in Germany.

She is currently working on her PhD funded by the FI scholarship granted by the Generalitat de Catalunya and the European Social Fund. Her thesis project is carried out within the Glycobiology group under the supervision of Luis Izquierdo. Her research focuses on studying the aminosugar pathway in Plasmodium falciparum, which may offer unprecedented opportunities for the design of antiparasitic drugs.

Líneas de investigación

• Glycobiology
• Plasmodium falciparum
• Malaria
• New drug targets

Principales publicaciones

• Alberione MP, González-Ruiz V, von Rohr O, Rudaz S, Soldati-Favre D, Izquierdo L, Kloehn J. N-acetylglucosamine supplementation fails to bypass the critical acetylation of glucosamine-6-phosphate required for Toxoplasma gondii replication and invasion. PLoS Pathog. 2024 Jun 20;20(6):e1011979. doi: 10.1371/journal.ppat.1011979. PMID: 38900808; PMCID: PMC11218972.
• Crispim M, Verdaguer IB, Hernández A, Kronenberger T, Fenollar À, Yamaguchi LF, Alberione MP, Ramirez M, de Oliveira SS, Katzin AM, Izquierdo L. Beyond the MEP Pathway: A novel kinase required for prenol utilization by malaria parasites. PLoS Pathog. 2024 Jan 26;20(1):e1011557. doi: 10.1371/journal.ppat.1011557. PMID: 38277417; PMCID: PMC10849223.
• Fenollar À, Ros-Lucas A, Pía Alberione M, Martínez-Peinado N, Ramírez M, Ángel Rosales-Motos M, Y Lee L, Alonso-Padilla J, Izquierdo L. Compounds targeting GPI biosynthesis or N-glycosylation are active against Plasmodium falciparum. Comput Struct Biotechnol J. 2022 Feb 2;20:850-863. doi: 10.1016/j.csbj.2022.01.029. PMID: 35222844; PMCID: PMC8841962.